RNA plays a vital role in how our genes are expressed and how diseases develop. Yet, because RNA molecules constantly change ...

Whether it’s the first supercomputer or the biotech boom, academia has helped launch industries — but too inconsistently. That’s changing.

AML is a devastating blood cancer with low survival rates, particularly for older patients who cannot tolerate aggressive chemotherapy. Flashpoint's approach offers the potential for a new precision ...

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer ...

The devastating retrovirus HTLV-1 has eluded scientists for decades. Overcoming chronic funding and other challenges, ...